Autolus Therapeutics plc (Nasdaq: AUTL), an early commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announces the online ...

ODP ( (ODP) ) has provided an announcement. On September 22, 2025, The ODP Corporation entered into a Merger Agreement with ACR Ocean Resources LLC and Vail Holdings 1, Inc., which will result in ODP ...

Autolus Therapeutics (AUTL) announces the online publication of an abstract submitted to the American College of Rheumatology, ACR, Convergence ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Update of ACR guidelines for systemic lupus ...

ACR Scores at 20%, 50%, and 70%. The mean percentages of patients reaching ACR 20, 50, and 70 with rituximab at 24 weeks were 40.9% (range 32.1–57.2%), 33.7% (range 26.7–40.6%), and 32.3% (range 22–38 ...

Please provide your email address to receive an email when new articles are posted on . “We have very convincing evidence that starting with triple therapy yields better long-term outcomes for our ...